BioMidwest
Filter News
Found 68,694 articles
-
BioSpace Hotbed maps have been a life sciences industry staple for over 30 years. Today the program features eight regional Hotbed Maps and the NextGen Bio Map which highlights some of the industry’s most promising startups.
-
BioSpace Movers & Shakers. Dec. 4
12/4/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock
12/4/2020
Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today announced an update to its plan to suspend its obligations to file periodic and current reports and other information with the U.S. Securities and Exchange Commission (the "Commission") under the Securities Exchange Act of 1934,
-
Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19
12/4/2020
Eli Lilly and Company (NYSE: LLY) and UnitedHealth Group (NYSE: UNH) today announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.
-
CMS grants transitional pass-through (TPT) payment for Stryker's SpineJack® System
12/4/2020
-The Centers for Medicare &; Medicaid Services (CMS) announced the SpineJack implantable fracture reduction system qualified for the Transitional Pass-Through (TPT) payment as part of the 2021 Medicare Hospital Outpatient Prospective Payment System.
-
Migraine class value-based contracts drive quality and value to payers and patients for Emgality® and REYVOW®
12/4/2020
Migraine is a disabling disease that costs families 70% more in health care expenses than families without a migraine sufferer
-
As if attempting to steal hard-won research wasn’t bad enough, hackers are now hitting people where it really hurts – with e-documents containing malicious code embedded in false offers of employment.
-
Therapies developed using E3 ligase proteins will get a potent infusion, as AbbVie combines its commercialization expertise with Frontier Medicine’s proprietary chemoproteomics platform to develop potentially efficacious therapies for difficult-to-drug protein targets.
-
3M to Advance Operating Model, Improve Cost Structure, and Accelerate Innovation
12/3/2020
As the global economy shifts in the wake of the COVID-19 pandemic, 3M is advancing its operating model, streamlining its business, and focusing on global trends where the company will apply science to life in new ways to drive sustainable growth.
-
McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care
12/3/2020
McKesson Corporation announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer.
-
Micro-Tech Endoscopy Launches New Dilation Balloon
12/3/2020
Micro-Tech Endoscopy USA rounds out the year with yet another product launch in the GI Dilation category.
-
On Target Laboratories Announces the Appointment of Tommy Lee as Vice President, Clinical Operations
12/3/2020
On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, today announced that Tommy Lee, MSHS has joined the Company as Vice President, Clinical Operations.
-
Cardinal Health Oncology Insights: Eighth Edition Explores Impact of COVID-19 on Oncologists
12/3/2020
In response to the COVID-19 pandemic, U.S. oncologists have adjusted patient care by embracing telemedicine and switching more patients to oral therapies to limit office visits—but personally, more oncologists may be experiencing burnout due to the loss of face-to-face interactions with patients, according to new research from Cardinal Health Specialty Solutions.
-
CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment StatusIncremental Reimbursement in Outpatient Setting Will Expand Availability of the Breakthrough BAROSTIM Therapy Heart Failure Treatment
12/3/2020
CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for Medicare and Medicaid Services (CMS) granted approval for a transitional pass-through (TPT) payment for BAROSTIM Therapy as part of the 2021 Outpatient Prospective Payment System (OPPS) Final Rule issued December 2, 202
-
Nexus Pharmaceuticals Announces Diversity Certification
12/3/2020
Nexus Pharmaceuticals is pleased to announce their continuous certification as a Minority Business Enterprise (MBE) and a Women’s Business Enterprise (WBE).
-
NeuroOne® Medical Technologies Corporation Announces First Human Commercial Use of its Evo™ Cortical Electrode at Mayo Clinic
12/3/2020
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the first human commercial use of its Evo Cortical Electrode at Mayo Clinic in Rochester, Minnesota .
-
EVERSANA and ArisGlobal announce strategic partnership to transform drug safety automation and advance integrated compliance models
12/3/2020
EVERSANA will leverage ArisGlobal's end-to-end LifeSphere Safety platform to strengthen next-generation commercialization services
-
New COVID-19 Testing Center Guarantees Same-Day PCR Test Results
12/3/2020
Cold and flu season in the midst of a pandemic means that every sniffle, sneeze, sore throat and cough is suspected to be COVID-19. When symptoms strike, you need immediate answers
-
Nonin Medical Named to Inc.'s Best in Business List in Health Products
12/3/2020
Nonin Medical, a global leader in noninvasive medical monitoring, has been named to Inc.'s inaugural Best in Business list in the Health Products category.
-
Services PMI™ at 55.9%; November 2020 Services ISM® Report On Business®
12/3/2020
Business Activity Index at 58%; New Orders Index at 57.2%; Employment Index at 51.5%; Supplier Deliveries Index at 57%